Segment Information (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Reportable Segment Information

	Three Months Ended
	March 31,
(DOLLARS IN MILLIONS)	2022		2021
Net sales:
Nourish	$	1,731	$	1,308
Health & Biosciences	661		426
Scent	585		569
Pharma Solutions	249		162
Consolidated	$	3,226	$	2,465
Segment Adjusted Operating EBITDA:
Nourish	$	329	$	270
Health & Biosciences	192		128
Scent	116		128
Pharma Solutions	65		43
Total	702		569
Depreciation & Amortization	(303)		(242)
Interest Expense	(72)		(65)
Other income, net	16		7
Restructuring and Other Charges	(2)		(4)
Shareholder Activism Related Costs (a)	(3)		(7)
Business Divestiture Costs (b)	(30)		—
Employee Separation Costs (c)	(4)		(3)
Frutarom Acquisition Related Costs (d)	(1)		—
N&B Inventory Step-Up Costs	—		(182)
N&B Transaction Related Costs (e)	—		(89)
Integration Related Costs (f)	(18)		(38)
Income (Loss) Before Taxes	$	285	$	(54)

_______________________

(a)	Represents shareholder activist related costs, primarily professional fees.
(b)	Represents costs related to the Company's planned sales of businesses, primarily legal and professional fees.
(c)	Represents costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated or will separate from the Company.
(d)	Represents transaction-related costs and expenses related to the acquisition of Frutarom.

(e)	Represents transaction costs and expenses related to the transaction with N&B, primarily includes legal and professional fees.
(f)	Represents costs related to integration activities since 2018, primarily for Frutarom and N&B. For 2022, represents costs primarily related to external consulting fees and internal integration costs, including salaries. For 2021, represents costs primarily related to performance stock awards and consulting fees for advisory services.

Net Sales by Destination of Product Delivery

Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:

	Three Months Ended March 31,
(DOLLARS IN MILLIONS)	2022		2021
Europe, Africa and Middle East	$	1,128	$	873
Greater Asia	744		587
North America	1,002		722
Latin America	352		283
Consolidated	$	3,226	$	2,465

	Three Months Ended March 31,
(DOLLARS IN MILLIONS)	2022		2021
Net sales related to the U.S.	$	901	$	654
Net sales attributed to all foreign countries	2,325		1,811